Loading…
Health Beauty Love received an FDA Warning Letter on July 10, 2020, regarding drug products, though the specific violations cannot be detailed as the full letter content is unavailable. Based on limited metadata, this warning indicates the company's drug products did not comply with FDA regulations, but the particular nature of the violations—whether related to manufacturing, labeling, claims, or other issues—cannot be determined without access to the complete correspondence. The warning falls under FDA's drug regulatory authority, though the specific originating office is not documented in this metadata record.